Salute e Benessere

Press Release: Sanofi and Regeneron’s Dupixent approved as the first targeted…

Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies showing Dupixent significantly reduced itch and hives at 24 weeks compared to placeboIn the EU, there are approximately 270,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite standard-of-care antihistamine treatmentDupixent, which inhibits IL4 and IL13, two key and central...
Nasdaq GlobeNewswire
25/11/2025

Vivoryon Therapeutics N.V. to Report Q3 2025 Financial Results and Operational…

Vivoryon Therapeutics N.V. to Report Q3 2025 Financial Results and Operational Progress on December 4, 2025Halle (Saale) / Munich, Germany, November 25 , 2025- Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a clinical stage company developing small molecule medicines for inflammatory and fibrotic disorders, with a primary focus on kidney diseases, today announced that it will publish its third quarter financial results for the period ended September...
Nasdaq GlobeNewswire
25/11/2025

XRP Healthcare LLC Expands First HIPAA-Grade, Open-Source XRPH Wallet Into U.S…

The wallet is available for free worldwide on Google Play and the App Store. The wallet is available for free worldwide onGoogle Play and the App Store . A Massive Addressable Market Across Two Strategic Healthcare Regions United States Healthcare Market East Africa Healthcare Market ( Kenya,Uganda,Rwanda,Tanzania ) Combined, these regions represent over 400,000 potential healthcare access points and a multi-hundred-billion-dollar transaction landscape...
PR Newswire
25/11/2025

Junshi Biosciences Announces Primary Endpoints Met in JS001sc’s Phase 3 Study…

According to data released by GLOBOCAN 2022, in 2022, China saw 1.06 million new lung cancer cases (22.0% of all new cancer cases in China) and 0.73 million lung cancer deaths (28.5% of all cancer-related deaths in China). NSCLC was the predominant subtype, accounting for approximately 85% of all lung cancer cases. Among NSCLC patients, non-squamous NSCLC constituted approximately 65% of cases.Immunotherapy (I-O), represented by anti-PD-1 monoclonal antibodies, has become a cornerstone...
Nasdaq GlobeNewswire
25/11/2025

Short Bowel Syndrome Market to Register Stunning Growth at a CAGR of 5% During…

Short Bowel Syndrome Market Summary Short Bowel Syndrome Market Summary Discover the new short bowel syndrome treatment @Short Bowel Syndrome Treatment Market Key Factors Driving the Growth of the Short Bowel Syndrome Market Rising SBS Prevalence The Short Bowel Syndrome market is largely driven by the increasing prevalence of gastrointestinal conditions that frequently require major bowel resections, resulting in a higher incidence of SBS. Unique GATTEX/REVESTIVE...
PR Newswire
24/11/2025

Novartis receives FDA approval for Itvisma®, the only gene replacement therapy…

Ad hoc announcement pursuant to Art. 53 LR Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III studiesOne-time dose of Itvisma replaces SMN1 gene, potentially reducing the need for chronic SMA treatmentGene replacement therapy now available to eligible people of all ages living with SMABasel, November 24, 2025– Novartis today announced that the US Food and Drug...
Nasdaq GlobeNewswire
24/11/2025

Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along…

Financial foundation toward self-sustained long-term growth established with the closing with HealthCare Royalty (“HCRx”) of a non-dilutive royalty financing valued up to $71 millionProgress in the JNJ-1900 (NBTXR3) global development program announced including first data from a Phase 1 esophageal cancer study sponsored by The University of Texas MD Anderson Cancer Center (“MD Anderson”)Completed the NANORAY-312 sponsorship transfer to Johnson & Johnson in the majority of regions...
Nasdaq GlobeNewswire
24/11/2025

Innocan Pharma Announces Promising Translational Evidence from a Pain Relief…

The results of this study offer clinically translatable information. LPT-CBD injections every 6 weeks are practical, have shown no adverse effects, and provide long-term CBD plasma concentrations. Additionally, LPT-CBD demonstrated remarkable efficacy trends in pain control and wellbeing improvement for several weeks and can potentially provide similar results in people. The results of this study offer clinically translatable information. LPT-CBD injections every 6 weeks are practical, have...
PR Newswire
24/11/2025

Information relating to the stabilization activities carried out in the context…

Daix (France), New York City (New York, United States), November 24, 202 5 – Publication of information relating to the stabilization activities carried out in the context of the recent public offering of Inventiva (the "Company" or "Inventiva") in the United States (the "Offering") of 38,961,038 American Depositary Shares ("ADSs"), each representing one ordinary share of the Company with a nominal value of €0.01. As announced on 18 November 2025, the…
Nasdaq GlobeNewswire
24/11/2025

U.S. Software as a Medical Device Market to Reach USD 715 Million by 2033 as…

From AI-based triage tools to remote cardiac monitoring and digital diabetes management platforms, SaMD is reshaping the care continuum, improving patient outcomes, and strengthening clinical efficiency across hospitals, ambulatory centers, and home-care settings. From AI-based triage tools to remote cardiac monitoring and digital diabetes management platforms, SaMD is reshaping the care continuum, improving patient outcomes, and strengthening clinical efficiency across hospitals, ambulatory...
PR Newswire
24/11/2025

CARBIOS signs two new multi-year commercial agreements for recycled PET with…

Clermont-Ferrand (France), 24 November 2025 (18h30 CET). CARBIOS(Euronext Growth Paris : ALCRB), announces the signing of two new multi-year commercial agreements with major players in beverage industry, for the supply of recycled PET (r-PET). The signing of these two new commercial agreements marks CARBIOS’s entry into a new strategic sector: beverages.These new commercial agreements are part of the pre-commercialization process for CARBIOS’s future industrial site, bringing the...
Nasdaq GlobeNewswire
24/11/2025

Press release: Transparency Notification from Shareholders

Transparency Notification from ShareholdersGhent, Belgium – 24 November 2025 – Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, announces today that it received a transparency notification in relation to the entities listed below, notifying the number of voting rights attached to the shares mentioned next to their name in the table…
Nasdaq GlobeNewswire
24/11/2025

Aesthetic Fillers Market Surges to USD 8.45 Billion by 2033, Propelled by 7.2%…

Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=837080&utm_source=PRNewswire&utm_medium=360 Download PDF Brochure:https://www.verifiedmarketreports.com/download-sample/?rid=837080&utm_source=PRNewswire&utm_medium=360 Browse in-depth TOCon Aesthetic Fillers Market 202 - Pages 126 – Tables 37 – Figures Scope of The Aesthetic Fillers Market Report Global Aesthetic Fillers Market Overview Hybrid fillers that blend...
PR Newswire
24/11/2025

Scott LaNeve Named President of Labstat International

LaNeve brings more than 30 years of leadership experience across life sciences, laboratory diagnostics, and healthcare technology. His career includes senior roles at industry leaders such as Abbott Laboratories, Roche Diagnostics, and Quest Diagnostics, as well as executive positions within national laboratory networks and technology organizations, where he led operational transformation and strengthened client engagement. LaNeve brings more than 30 years of leadership experience across life...
PR Newswire
24/11/2025

Cosmetic Dentistry Market is expected to generate a revenue of USD 42.79 Billion…

For a detailed analysis of Industry Trends And Growth Drivers, Explore The Full Cosmetic Dentistry Market. For a detailed analysis of Industry Trends And Growth Drivers, Explore The Full Cosmetic Dentistry Market . Browse in-depth TOC 202 - Pages 126 – Tables 37 – Figures Global Cosmetic Dentistry Market Overview Market Driver 1. Rising Demand for Aesthetic Enhancement and Smile Transformation 2. Adoption of Advanced Dental Technologies...
PR Newswire
24/11/2025

Biochips Market worth $21.36 billion by 2030 with 8.8% CAGR | MarketsandMarkets™

Browse in-depth TOC on "Biochips Market" Browse in-depth TOC on "Biochips Market" 300 - Tables65 - Figures 350 - Pages By products & services,the biochips market is categorized into instruments, consumables, and software & services. The consumables segment is projected to grow at the highest CAGR during the forecast period, as biochip technologies generate vast and complex datasets that require advanced analytics and AI-based interpretation. Cloud integration...
PR Newswire
24/11/2025

Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be…

The presentations include an oral session highlighting results from a triplet therapy combining tagraxofusp, azacitidine, and venetoclax, which demonstrated both efficacy (high response and bridge to transplant rates) and tolerability in individuals with blastic plasmacytoid dendritic cell neoplasm (BPDCN). "At Menarini Stemline, our commitment to transforming the lives of people living with difficult-to-treat cancers is unwavering," said Elcin Barker Ergun, CEO of the Menarini…
PR Newswire
24/11/2025

Regenerative Medicine Market to Skyrocket to USD 403.86 Billion by 2032 Driven…

Download PDF Brochure: https://www.datamintelligence.com/download-sample/regenerative-medicine-market Download PDF Brochure:https://www.datamintelligence.com/download-sample/regenerative-medicine-market Browse in-depth TOC on "Regenerative Medicine Market"60 – Tables 50 – Figures 176 – Pages Regenerative Medicine: A New Era of Curative, Transformative Therapies 1. Cell & gene therapy approvals gaining momentum Over the last 36 months, approvals for CAR-T...
PR Newswire
24/11/2025

Alzheimer's Association Statement on Oral Semaglutide Phase 3 Topline Data…

"While these results are not what we had hoped for, they will contribute to our understanding of this devastating and fatal disease," said Joanne Pike, DrPH, Alzheimer's Association president and chief executive officer. "The data from every clinical trial, regardless of outcome, is vital to accelerating our understanding of this disease and helps inform the next generation of clinical trials. We remain optimistic about the future of Alzheimer's treatment and prevention, as the…
PR Newswire
24/11/2025

Philips launches next-generation web-based diagnostic viewer for fast, secure…

New viewer offers full radiology capabilities, interfaces with AI and interactive reporting module to streamline workflows Amsterdam, the Netherlands –Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Management 15, the next generation of Philips Vue PACS, including a zero-footprint,web diagnostic viewer[1] that transforms how radiologists access and interpret medical images. Designed with a brand-new user...
Nasdaq GlobeNewswire
24/11/2025

Enlivex Announces $212,000,000 Private Placement to Initiate World’s First…

- Upon the closing of the private placement, Enlivex will adopt the world’s first RAIN prediction markets token digital asset treasury strategy, via RAIN token accumulation.- RAIN is a fully decentralized predictions and options protocol that redefines predictive market ecosystems and provides a powerful platform for on-chain market creation - built for transparency, automation, and community participation.- Mr. Matteo Renzi, former Prime Minister of Italy, will be appointed to the...
Nasdaq GlobeNewswire
24/11/2025

Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and…

Oral macrocyclic peptides have the potential to offer biologic-like efficacy and safety in a convenient oral formatCollaboration further advances Biogen’s immunology strategy by broadening its early-stage pipeline and incorporating an additional clinically validated modality into its expanding immunology capabilities CAMBRIDGE, Mass. and TORONTO, Nov.24, 2025(GLOBE NEWSWIRE) --BiogenInc. (Nasdaq: BIIB) and Dayra Therapeutics today announced a research collaboration to discover and...
Nasdaq GlobeNewswire
24/11/2025

Loftware Celebrated Among the World's Top Healthcare Technology Innovators of…

Loftware was selected for its cloud-based labeling and packaging technologies designed to support the complex operational and regulatory demands faced by medical device manufacturers, pharmaceutical companies, and broader life sciences organizations. With increasing global regulatory pressures, from U.S. FDA requirements to EU MDR and global UDI regulations, Loftware enables customers to automate, centralize, and standardize labeling processes while mitigating risk, enhancing traceability, and…
PR Newswire
24/11/2025

Veeva Announces Expanded Partnership with Roche

"Roche and Veeva have partnered for many years," said Veeva CEO Peter Gassner. "We are honored to extend our partnership to Vault CRM and bring the next generation of AI-enabled CRM to the global Roche Pharma field teams." "Roche and Veeva have partnered for many years," said Veeva CEOPeter Gassner. "We are honored to extend our partnership to Vault CRM and bring the next generation of AI-enabled CRM to the global Roche Pharma field teams." "We're…
PR Newswire
24/11/2025
Altri  Comunicati